RYMCX
Price
$6.00
Change
-$0.17 (-2.76%)
Updated
Apr 8 closing price
Net Assets
227.67M
VSCIX
Price
$92.85
Change
-$2.45 (-2.57%)
Updated
Apr 8 closing price
Net Assets
143.36B
Ad is loading...

RYMCX vs VSCIX

Header iconRYMCX vs VSCIX Comparison
Open Charts RYMCX vs VSCIXBanner chart's image
Royce Micro-Cap Consult
Price$6.00
Change-$0.17 (-2.76%)
VolumeN/A
Net Assets227.67M
Vanguard Small Cap Index I
Price$92.85
Change-$2.45 (-2.57%)
VolumeN/A
Net Assets143.36B
RYMCX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYMCX vs. VSCIX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYMCX is a Hold and VSCIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 143B vs. RYMCX (228M). VSCIX pays higher dividends than RYMCX: VSCIX (1.53) vs RYMCX (0.00). RYMCX was incepted earlier than VSCIX: RYMCX (27 years) vs VSCIX (28 years). RYMCX (2.42) is less costly to investors than VSCIX (0.04). RYMCX has a lower initial minimum investment than VSCIX: RYMCX (2000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : -11.10 vs. RYMCX (-27.10). VSCIX return over 5 years is better than : 60.68 vs. RYMCX (-2.28).
RYMCXVSCIXRYMCX / VSCIX
Total Expense Ratio2.240.045,600%
Annual Report Gross Expense Ratio2.420.046,050%
Fund Existence27 years28 years-
Gain YTD-25.558-17.160149%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets228M143B0%
Annual Yield % from dividends0.001.53-
Returns for 1 year-27.10-11.10244%
Returns for 3 years-27.80-2.601,068%
Returns for 5 years-2.2860.68-4%
Returns for 10 years-51.2267.93-75%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRG64.510.15
+0.23%
Evergy
MBWM39.49-0.36
-0.89%
Mercantile Bank Corp
SLVM55.99-1.69
-2.93%
Sylvamo Corp
DRMA0.84-0.05
-5.23%
Dermata Therapeutics Inc.
GLSI9.07-0.52
-5.42%
Greenwich LifeSciences